Related Experiment Videos
Phase II evaluation of piperazinedione in metastatic breast carcinoma
Cancer Treatment Reports
|December 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A comparative study of South Asian and non-Asian referrals to an eating disorders service in Leicester, UK.
European eating disorders review : the journal of the Eating Disorders Association·2010
Simple graphical methods of displaying multiple clinical results.
Pharmaceutical statistics·2006
Biomagnetic characterization of spatiotemporal parameters of the gastric slow wave.
Neurogastroenterology and motility·2006
No evidence that panic attacks are associated with the white coat effect in hypertension.
Journal of clinical hypertension (Greenwich, Conn.)·2003
Childhood trauma has dose-effect relationship with dropping out from psychotherapeutic treatment for bulimia nervosa: a replication.
The International journal of eating disorders·2001
Do broken relationships in childhood relate to bulimic women breaking off psychotherapy in adulthood?
The International journal of eating disorders·2001
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
A Systematic Intracranial Exposure-Response Evaluation of Brain-Penetrant Inhibitors: Informing Dose Selection for Brain Metastases.
Clinical and translational science·2026
Targeting Vascular Smooth Muscle Cell Senescence for Cardiovascular Pharmacology: Mechanisms and Therapeutic Perspectives.
Journal of cardiovascular pharmacology·2026
Insights into the degradation behaviour of tucatinib under stress conditions using liquid chromatography high resolution tandem mass spectrometry.
Analytical methods : advancing methods and applications·2026
Engineered dual RNAi prodrug for combined suppression of survival and cell cycle pathways in triple negative breast cancer treatment.
Chemical communications (Cambridge, England)·2026
Harnessing Functionalized Nano Lipid Carriers for Cardioprotection: Dual Drug Delivery in Focus for Precision Therapeutics.
Drug development and industrial pharmacy·2026